Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
NewsMost COPD patients discharged after a flare-up aren't getting the right inhalers. A new study found that only 10% of patients left the hospital on a fully guideline-consistent inhaler regimen, with recommended dual bronchodilators underused and inhaled corticosteroids overprescribed. Researchers say better adherence to GOLD guidelines is urgently needed.
When COPD patients leave the hospital after an exacerbation, they should be set up with the right inhalers — but a new study suggests that's rarely happening. Presented at the CHEST Annual Meeting, a retrospective review of 145 patients found that discharge prescribing patterns frequently deviated from GOLD guideline recommendations, potentially putting patients at risk for repeat hospitalizations.
The GOLD guidelines recommend dual bronchodilation — a long-acting beta agonist (LABA) plus a long-acting muscarinic agent (LAMA) — for patients hospitalized with COPD exacerbations. Yet only 32% of patients received this combination at discharge. Meanwhile, inhaled corticosteroids (ICS) were prescribed to 78% of patients, even though only 25% of those actually met the guideline criteria for ICS use.
By the Numbers:
Why it matters: Misaligned prescribing at discharge isn't just a guideline compliance issue — it has real consequences. All 11 patients readmitted within 30 days had been on non-guideline-adherent regimens. Researchers are now planning a quality improvement project to close these gaps.
